Capstone Investment Advisors
PRPH

Capstone Investment Advisors’s ProPhase Labs PRPH Stock Holding History

Capstone Investment Advisors’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,196
Closed -$110K – 1897
2020
Q4 		$110K Buy
+1,196
New +$100K ﹤0.01% 1543

Other funds holding PRPH

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
KSCM
Kamunting Street Capital Management Miami Beach, Florida $179M AUM 5.77% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Capstone Investment Advisors's PRPH Position: Q1 2021 in Review

Capstone Investment Advisors sold out of ProPhase Labs (PRPH) in Q1 2021, closing a stake of 1,196 shares — an estimated $110K sold.

Capstone Investment Advisors first reported a position in PRPH in Q4 2020 and held it in 1 quarter. The position peaked at $110K in Q4 2020. 28 funds tracked by Wall St. Rank hold PRPH as of Q1 2021.

  • Capstone Investment Advisors reported no remaining ProPhase Labs position as of Q1 2021 after selling out during the quarter.
  • Capstone Investment Advisors sold 1,196 ProPhase Labs shares in Q1 2021, an estimated $110K.
  • Capstone Investment Advisors first reported a position in ProPhase Labs in Q4 2020 and held it in 1 quarter.
  • Capstone Investment Advisors's ProPhase Labs position peaked at $110K in Q4 2020.
  • 28 funds tracked by Wall St. Rank held ProPhase Labs as of Q1 2021.

Based on Capstone Investment Advisors's 13F filing for Q1 2021, filed 17 May 2021.